ReAlta Life Sciences
John Rickman is an accomplished finance executive with extensive experience across various sectors. Currently serving as Chief Financial Officer at ReAlta Life Sciences, Inc. since December 2018, Rickman also holds the position of Founding Member at The F Suite, an exclusive peer community for CFOs. Prior experience includes roles as Chief Financial Officer and Chief Operating and Financial Officer at Beaufort CRO, where responsibilities included enhancing medical innovation through a range of customizable services. Rickman previously contributed as VP of Corporate Development at Expedient, where strategic acquisitions significantly expanded the firm's market presence. Earlier roles included New Ventures Director at Landmark Communications, Senior Financial Analyst at General Motors, and Associate at JP Morgan. Educational qualifications include an MBA in Finance and General Management from the University of Virginia Darden School of Business and a Bachelor of Science in Mechanical Engineering from the University of Virginia.
ReAlta Life Sciences
ReAlta Life Sciences, Inc. is an early stage pharmaceutical company incorporated in late, 2018, and located in Norfolk, Virginia. ReAlta was initially formed as a joint venture between Children’s Hospital of The King’s Daughters, Children’s Specialty Group (170 multispecialty pediatricians) and Eastern Virginia Medical School. ReAlta is dedicated to addressing life-threatening medical needs through beneficial inhibition of the Complement System and Inflammatory Mechanisms. To support this mission, ReAlta has developed a New Class of Drugs that can address unmet medical needs through unique Multi-Modal Therapeutic Capabilities.